UPDATE 3-McKesson, CD&R near $5 billion-plus deal to buy Option Care, FT reports

4

(Adds analyst quote in paragraph 5) By Sahil Pandey Oct 5 (Reuters) – Drug distributor McKesson and private equity firm Clayton Dubilier & Rice are nearing a deal to acquire infusion services provider

(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)